Walgreens Boots Alliance (WBA) Director Granted 11,774 Shares, 5,046 Phantom Units
Rhea-AI Filing Summary
Thomas E. Polen Jr., a director of Walgreens Boots Alliance, acquired equity compensation on 08/13/2025. The filing shows an annual non-employee director stock award of 11,774 common shares issued under the company's 2021 Omnibus Incentive Plan for services rendered the prior year, and an annual phantom stock grant of 5,046.26 units, each unit economically equivalent to one share. Following these grants, Mr. Polen beneficially owned 28,269 common shares and 12,356.58 shares represented by phantom units (including units issued in lieu of dividends). The phantom units are to be settled following termination of director service per the Plan.
Positive
- Equity alignment: Director compensation granted in both common stock and phantom stock units, aligning the director's economic interests with shareholders
- Transparent disclosure: Form 4 clearly states grant amounts, plan basis, and settlement terms for phantom units
Negative
- None.
Insights
TL;DR: Routine director compensation issued as stock and phantom units; not a material corporate event.
This Form 4 discloses typical non-employee director compensation: an annual equity grant in shares and phantom stock units tied to service for the prior year. The reported amounts—11,774 shares and 5,046.26 phantom units—increase the director's economic exposure to WBA equity but do not reflect purchases or dispositions funded by market activity. There is no indication of additional corporate actions, and the grants are described as issued in arrears under the Omnibus Incentive Plan, with phantom units settling on termination of service.
TL;DR: Disclosure aligns with standard governance practices for director compensation via equity and phantom units.
The filing documents standard governance practice of compensating non-employee directors with equity and deferred phantom units. The inclusion of phantom units that accrue dividend equivalents is common and intended to align director incentives with shareholder interests. The filing is transparent about the plan-based nature of the awards and settlement timing upon termination of service, meeting disclosure expectations for insider reporting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units | 5,046.26 | $11.89 | $60K |
| Grant/Award | Common Stock | 11,774 | $0.00 | -- |
Footnotes (1)
- Annual share grant issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (the "Plan") in arrears with respect to services rendered over the course of the prior year. The annual phantom stock grant is issued as non-employee director compensation under the Plan in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock. To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. Includes phantom stock units that were issued in lieu of dividends on outstanding phantom stock units.